Sign Up Today and Learn More About Harbinger Health Stock
Invest in or calculate the value of your shares in Harbinger Health or other pre-IPO companies through EquityZen's platform.
Harbinger Health Stock (HAHE)
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
About Harbinger Health Stock
Founded
2018
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Harbinger Health Press Mentions
Stay in the know about the latest news on Harbinger Health
Harbinger Health Presents Multiple Studies at AACR Reinforcing Platform Foundation for RESOLVE™, a New Category for Cancer Detection
prnewswire • Apr 17, 2026
Beeline raises $300m for BMS drugs, and other biofinancings
pharmaphorum • Apr 17, 2026
美国早期癌症检测技术开发商Harbinger Health获得1亿美元战略投资
ifastdata • Apr 16, 2026
Cambridge company secures $100M as it prepares to launch multi-cancer detection tests
bizjournals • Apr 14, 2026
Harbinger Health Establishes RESOLVE™ as a New Category for Cancer Detection
morningstar • Apr 14, 2026
Harbinger Health Management
Leadership team at Harbinger Health
Chief Commercial Officer
Dymeka Harrison
Chief Business Officer
Mathew Sargent
Join now and verify your accreditation status to gain access to:
- Harbinger Health Current Valuation
- Harbinger Health Stock Price
- Harbinger Health Management
- Available deals in Harbinger Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Harbinger Health Cap Table and Funding History by Share Class and Liquidity Preferences
- Harbinger Health Revenue and Financials
- Harbinger Health Highlights
- Harbinger Health Business Model
- Harbinger Health Risk Factors
- Harbinger Health Research Report from SACRA Research
Trading Harbinger Health Stock
How to invest in Harbinger Health stock?
Accredited investors can buy pre-IPO stock in companies like Harbinger Health through EquityZen funds. These investments are made available by existing Harbinger Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Harbinger Health stock?
Shareholders can sell their Harbinger Health stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
